Investors scramble over Vitality amid dearth of life deals
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

Investors scramble over Vitality amid dearth of life deals

14 February 2014
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn

Aetna benefited from a shortage of life-linked risk on the ILS market as it kicked off 2014 activity with a $200mn Vitality Re issuance.

Request a free trial:

Fuel a smarter strategy with our actionable market intelligence

    • Gain a competitive edge and accelerate decision-making
    • Be empowered by insights that transform confusion to clarity
    • Uncover growth opportunities and prepare for potential threats
Request a free trial Already a subscriber? Log in now

Topics

NewsCatastrophe bondsFebruary 2014/1
Gift this article